Income investors can buy in May and go away with these stocks.
The pharma-giant's shares could be poised for a trend reversal.
PFE earnings call for the period ending March 31, 2024.
A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.
June S&P 500 E-Mini futures (ESM24) are down -0.42%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.73% this morning as mixed earnings and the prospect of higher-for-longer U.S. interest rates...
In late April, Pfizer (NYSE:PFE) and Genmab received approval from the United States Food and Drug Administration ...
/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...
USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...